Cannabidiol for seizures in tuberous sclerosis complex: Still more questions than answers?

Epilepsy Behav. 2022 Jul:132:108701. doi: 10.1016/j.yebeh.2022.108701. Epub 2022 May 14.

Authors

Francesco Brigo¹, Sasha Olivo²

Affiliations

¹ Department of Neurology, Hospital of Merano (SABES-ASDAA), Merano, Italy. Electronic address: dr.francescobrigo@gmail.com.
² Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste - ASUGI, University of Trieste, Trieste, Italy.

PMID: 35581136
DOI: 10.1016/j.yebeh.2022.108701

No abstract available

Keywords: Cannabidiol; Clobazam; Efficacy; Seizures; Tuberous sclerosis.

Publication types

Letter
Comment

MeSH terms

Anticonvulsants / therapeutic use
Cannabidiol* / therapeutic use
Humans
Seizures / drug therapy
Seizures / etiology
Tuberous Sclerosis* / complications
Tuberous Sclerosis* / drug therapy

Substances

Anticonvulsants
Cannabidiol